A three-pronged approach was followed for deducing the medical polymer market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for medical polymer market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of medical polymer market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The medical polymer market was categorized into three segments, namely products (Fibers & Resins, Medical Elastomers, Biodegradable Polymers), application (Medical Device Packaging, Medical Components, Orthopedic Soft Goods, Wound Care, Cleanroom Supplies, BioPharm Devices, Mobility Aids, Sterilization & Infection Prevention, Tooth Implants, Denture-based Materials), and regions (North America, Europe, Asia Pacific, Central & South America, Middle East & Africa).
The medical polymer market was segmented into products, application, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The medical polymer market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into seventeen countries, namely, the U.S.; Canada; Mexico; the UK.; Germany; France; Italy; China; India; Japan; Malaysia; Singapore; Oceania; Brazil; Argentina; Saudi Arabia; South Africa.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The medical polymer market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
BASF SE - BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE. The company's business is spread across six segments including chemicals, materials, industrial solutions, surface technologies, nutrition & care, and agricultural solutions. Products offered by the company find use in industries such as agriculture, construction, pharmaceuticals, energy & power, home care & nutrition, automotive & transportation, rubber & plastics, leather & textiles, and personal care & hygiene. BASF markets medical polymers under the brand names Ultraform PRO (POM), Ultradur PRO (PBT), Elastollan, Ultramid, and Elastopor.
NatureWorks LLC - The company has set up an advanced biopolymer research facility as its USA headquarters. It offers a broad portfolio of renewably sourced polymers and chemicals under the brand named Ingeo Biomaterials, which finds applications in 3D printing, medical & hygiene, and food & beverage packaging. The company has a manufacturing facility in Blair, Nebraska, U.S., with a capacity of 330 million pounds of Ingeo biopolymers. It has representatives in over 10 countries and businesses in North America, Europe, Japan, and Asia Pacific.
Covestro AG - The company is focused on the manufacturing of high-tech polymer materials and the development of innovative, sustainable solutions for products used in many applications. Covestro AG is majorly divided into three reportable segments, namely Polyurethanes (PUR); Polycarbonates (PCS); and Coatings, Adhesives, and Specialties (CAS). The main industries served by the company are automotive, construction, furniture and wood processing, electrical, electronics, and household appliances industries. As of December 31, 2020, Covestro had 33 production sites worldwide.
Celanese Corporation - The company operates through six business segments, namely engineered materials, cellulose derivatives, intermediate chemistry, food ingredients, ethylene vinyl acetate (EVA) polymers, and emulsion polymers. It caters its products to various end-use industries including aerospace & defense, automotive & transportation, construction, chemicals, energy, food & beverage, medical & pharma, packaging, consumer goods, and utility. Engineered materials and EVA polymer segments include a variety of plastic materials, such as different types of polyesters, thermoplastics, and polymers, catering to various end-use industries such as construction, electrical & electronics, packaging, and automotive. As of December 31, 2020, Celanese Corporation’s operations are primarily located in North America, Europe, and Asia and consist of 33 global production facilities and an additional 6 strategic affiliate production facilities.
Eastman Chemical Corporation - The company operates through four business segments, namely additives & advanced materials, functional products, fibers, and chemical intermediates, and serves various end-use industries including automotive & transportation, construction, consumer goods, chemicals, agriculture, food & beverage, and health & wellness. Plastics and plastic additives manufactured by the company are used in various applications including carpet, floors, insulation, furniture, and window films in construction; bumpers, carpets, and other interior applications in automotive; bottles, toys, storage containers, and others in utility; packaging; and medical devices. The company is traded on the New York Stock Exchange.
Evonik Industries AG - The company operates through three business segments, namely Nutrition & care, performance materials, and resource efficiency. It caters to various end-use industries including adhesives & sealants, agriculture, automotive, composites, construction, food, pharmaceutical, energy, paints & coatings, and tire & rubber. The company has manufacturing facilities in countries including the U.S., Canada, Mexico, Argentina, Brazil, France, Britain, Germany, New Zealand, China, India, Japan, and South Africa.
Dow Inc. - It is headquartered in Midland, U.S. The company operates through three segments, namely industrial intermediates & infrastructure; performance materials & coatings; and packaging & specialty plastics. It caters products & services to the needs of various end-use industries such as consumer goods, healthcare, food & beverage, personal care, construction, life sciences, paints & coatings, and paper. As of December 2020, the company had 106 manufacturing facilities in countries including the U.S., India, Thailand, and South Africa and catered its products to 31 countries.
Exxon Mobil Corporation - The company is headquartered in Texas, U.S., and is traded on the New York Stock Exchange. It has four business divisions, namely upstream, chemical, downstream, and natural gas and power marketing. The chemical division of the company includes plastics, rubber, plasticizers, acids, additives, solvents & fluids, and others. The division caters to end-use industries including automotive, construction, lubricants, medical & healthcare, oil & gas, consumer goods, utility, and packaging. Plastics include polyethylene, polypropylene, and polymer modifiers of grades such as high-density polyethylene, low-density polyethylene, linear low-density polyethylene, plastomers, advanced polypropylene, and performance polyolefin. The company has manufacturing facilities in North America, South America, Europe, Asia Pacific, and the Middle East & Africa and serves the market needs in these regions.
Arkema - The company has segmented its product portfolio into eight categories, namely plastics & additives, 3D printing, adhesives, air-conditioning & refrigeration, bio-sourced materials, composite materials, energy storage, and paints & coatings. It caters to end-use industries including construction, electrical & electronics, food & agrochemicals, health, hygiene & beauty, oil & gas, paper & packaging, renewable energies, sports, and transportation. Products of the plastics and additives segment are used in applications including the manufacturing of rubber, textiles, pesticides, paints, pharmaceuticals & cosmetics, coatings, synthesizing of polymers, and as metal substitutes for pipes & valves. Plastics & additive intermediates are used to enhance the physical and chemical properties of raw materials used in the manufacturing processes. The company is traded on the Paris Stock Exchange. It has over 137 manufacturing facilities spread across 38 countries in Europe, North America, South America, Asia Pacific, and the Middle East & Africa.
Koninklijke DSM NV - The company operates in the fields of nutrition, health, and sustainable living. It provides solutions for animal nutrition and feed, food & beverages, pharmaceuticals, medical nutrition, early life nutrition, nutrition improvement, dietary supplements, and personal care. DSM is involved in every stage across the value chain, from the production of pure active ingredients through its incorporation into sophisticated forms, as well as custom premixes, advanced solutions, and branded consumer products. Moreover, as of December 31, 2020, Koninklijke DSM NV had annual net sales of about USD 9.95 billion. The company has a presence across five continents.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
revenue/volume
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.